HEPION PHARMACEUTICALS, INC.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2020 | $8.1M | $48.6M | $40.7M |
| FY2021 | $10.6M | $103.6M | $91.3M |
| FY2022 | $10.4M | $60.2M | $51.2M |
| FY2023 | $10.8M | $18.1M | $14.8M |
| FY2024 | $3.5M | $1.6M | $406.4K |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2020 | $8.1M | $48.6M | $40.7M |
| FY2021 | $10.6M | $103.6M | $91.3M |
| FY2022 | $10.4M | $60.2M | $51.2M |
| FY2023 | $10.8M | $18.1M | $14.8M |
| FY2024 | $3.5M | $1.6M | $406.4K |